Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms

Human Molecular Genetics

Volumn 19, Issue 2, 2009, Pages 387-395

  van der Harst, Pim ^a   Bakker, Stephan J L ^a   de Boer, Rudolf A ^a   Wolffenbuttel, Bruce H R ^a   Johnson, Toby ^b   Caulfield, Mark J ^b   Navis, Gerjan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATININE; GLUCOKINASE; GLUCOKINASE REGULATOR PROTEIN; GLUCOSE; MEMBRANE PROTEIN; PDZ PROTEIN; UNCLASSIFIED DRUG; URIC ACID; GCKR PROTEIN, HUMAN; ORGANIC ANION TRANSPORTER; PDZK1IP1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SLC22A11 PROTEIN, HUMAN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CATABOLISM; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; GENE LOCUS; GENE REPLICATION; GENOME ANALYSIS; HUMAN; INSULIN RESISTANCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PRIORITY JOURNAL; PURINE METABOLISM; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; CAUCASIAN; COHORT ANALYSIS; FEMALE; GENETICS; MALE; MIDDLE AGED; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC LOCI; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; TRIGLYCERIDES; URIC ACID;

EID: 77949483365     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp489     Document Type: Article

References (23)

1. Feig, D.I., Kang, D.H. and Johnson, R.J. (2008) Uric acid and cardiovascular risk. N. Engl. J. Med., 359, 1811-1821.
2. Hayden, M.R. and Tyagi, S.C. (2004) Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutr. Metab (Lond), 1, 10.
3. Nagahama, K., Iseki, K., Inoue, T., Touma, T., Ikemiya, Y. and Takishita, S. (2004) Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens. Res., 27, 227-233.
4. Pacifico, L., Cantisani, V., Anania, C., Bonaiuto, E., Martino, F., Pascone, R. and Chiesa, C. (2009) Serum uric acid and its association with metabolic syndrome and carotid atherosclerosis in obese children. Eur. J. Endocrinol., 160, 45-52.
5. Schmidt, M.I., Watson, R.L., Duncan, B.B., Metcalf, P., Brancati, F.L., Sharrett, A.R., Davis, C.E. and Heiss, G. Atherosclerosis Risk in Communities Study Investigators (1996) Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Metabolism, 45, 699-706.
6. Kolz, M., Johnson, T., Sanna, S., Teumer, A., Vitart, V., Perola, M., Mangino, M., Albrecht, E., Wallace, C., Farrall, M. et al. (2009) Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet., 5, e1000504.
7. Orho-Melander, M., Melander, O., Guiducci, C., Perez-Martinez, P., Corella, D., Roos, C., Tewhey, R., Rieder, M.J., Hall, J., Abecasis, G. et al. (2008) Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Diabetes, 57, 3112-3121.
8. Saxena, R., Voight, B.F., Lyssenko, V., Burtt, N.P., de Bakker, P.I., Chen, H., Roix, J.J., Kathiresan, S., Hirschhorn, J.N., Daly, M.J. et al. (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science, 316, 1331-1336.
9. Ridker, P.M., Pare, G., Parker, A., Zee, R.Y., Danik, J.S., Buring, J.E., Kwiatkowski, D., Cook, N.R., Miletich, J.P. and Chasman, D.I. (2008) Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am. J. Hum. Genet., 82, 1185-1192.
10. Aulchenko, Y.S., Ripatti, S., Lindqvist, I., Boomsma, D., Heid, I.M., Pramstaller, P.P., Penninx, B.W., Janssens, A.C., Wilson, J.F., Spector, T. et al. (2009) Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat. Genet., 41, 47-55.
11. Kathiresan, S., Willer, C.J., Peloso, G.M., Demissie, S., Musunuru, K., Schadt, E.E., Kaplan, L., Bennett, D., Li, Y., Tanaka, T. et al. (2009) Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet., 41, 56-65.
12. Van, S.E. (1994) Short-term regulation of glucokinase. Diabetologia, 37 (Suppl 2), S43-S47.
13. de la Iglesia, N., Veiga-da-Cunha, M., Van Schaftingen, E., Guinovart, J.J. and Ferrer, J.C. (1999) Glucokinase regulatory protein is essential for the proper subcellular localisation of liver glucokinase. FEBS Lett., 456, 332-338.
14. Yang, C.J. and Mansfield, B.C. (1999) Molecular genetics of type 1 glycogen storage diseases. Trends Endocrinol. Metab., 10, 104-113.
15. Anzai, N., Miyazaki, H., Noshiro, R., Khamdang, S., Chairoungdua, A., Shin, H.J., Enomoto, A., Sakamoto, S., Hirata, T., Tomita, K. et al. (2004) The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C terminus. J. Biol. Chem., 279, 45942-45950.
16. Anzai, N., Kanai, Y. and Endou, H. (2007) New insights into renal transport of urate. Curr. Opin. Rheumatol., 19, 151-157.
17. Navarro-Lerida, I., Martinez-Moreno, M., Ventoso, I., Varez-Barrientos, A. and Rodriguez-Crespo, I. (2007) Binding of CAP70 to inducible nitric oxide synthase and implications for the vectorial release of nitric oxide in polarized cells. Mol. Biol. Cell, 18, 2768-2777.
18. Johnson, R.J., Perez-Pozo, S.E., Sautin, Y.Y., Manitius, J., Sanchez-Lozada, L.G., Feig, D.I., Shafiu, M., Segal, M., Glassock, R.J., Shimada, M. et al. (2009) Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr. Rev., 30, 96-116.
19. Sheehan, N.A., Didelez, V., Burton, P.R. and Tobin, M.D. (2008) Mendelian randomisation and causal inference in observational epidemiology. PLoS Med., 5, e177.
20. Hillege, H.L., Fidler, V., Diercks, G.F., van Gilst, W.H., de, Z.D., van Veldhuisen, D.J., Gans, R.O., Janssen, W.M., Grobbee, D.E. and de Jong, P.E. (2002) Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation, 106, 1777-1782.
21. Pinto-Sietsma, S.J., Janssen, W.M., Hillege, H.L., Navis, G., de, Z.D. and de Jong, P.E. (2000) Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J. Am. Soc. Nephrol., 11, 1882-1888.
22. Mostert, J.P., Ramsaransing, G.S., Heersema, D.J., Heerings, M., Wilczak, N. and De, K.J. (2005) Serum uric acid levels and leukocyte nitric oxide production in multiple sclerosis patients outside relapses. J. Neurol. Sci., 231,41-44.
23. Mora, S., Cook, N., Buring, J.E., Ridker, P.M. and Lee, I.M. (2007) Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation, 116, 2110-2118.